Please try another search
For the six months ended 30 June 2017, Alere Inc revenues decreased 4% to $1.15B. Net loss applicable to common stockholders increased from $49.6M to $167.9M. Revenues reflect Professional Diagnostics segment decrease of 54% to $504.4M, Other Non reportable Segment decrease of 49% to $36.8M, Consumer Diagnostic Products segment decrease of 56% to $16.5M.
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Total Revenue | 557.67 | 588.22 | 604.68 | 582.35 |
Gross Profit | 253.73 | 282.54 | 277.71 | 267.66 |
Operating Income | -29 | -5.02 | -39.49 | 3.43 |
Net Income | -93.07 | -64.31 | -114.33 | 21.82 |
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Total Assets | 5556.84 | 5673.87 | 5648.28 | 5855.67 |
Total Liabilities | 3796.43 | 3858.05 | 3821.29 | 3809.99 |
Total Equity | 1760.41 | 1815.82 | 1826.99 | 2045.68 |
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | 10 | 61.08 | 179.29 | 146.96 |
Cash From Investing Activities | -26.72 | -14.69 | 2.63 | 11.34 |
Cash From Financing Activities | -70.18 | -21.52 | -109.82 | -99.11 |
Net Change in Cash | -75.52 | 34.26 | 65.02 | 64.01 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review